Leadership Team
Meet our experienced team.
We ensure you take the best antibody candidates forward.
At Abzena we tailor our antibody discovery services to your needs. We deliver expert assessments of target molecules, immunization strategies and antibody screening cascades.
We apply innovative approaches and equipment to generate robust data that ensures optimal antibody discovery and supports the selection of the best antibody candidates for your drug development program.
Our Hybridoma MAX™ custom mouse monoclonal antibody discovery service maximizes the number of antibodies discovered through a dual, high-throughput screening platform that creates more candidates for development.
Our antibody discovery methods ensure high affinity antibodies and where required cross-reactivity with the target, and include:
Hybridoma Sequencing
Having a 100% accurate sequence is crucial. Especially true if your antibody sequence is to be used for downstream activities such as recombinant antibody production or antibody humanization. Unlike some methods that can introduce mutations at the start, by using primers specifically designed to bind in the leader sequence, Abzena can determine the authentic start to an antibody variable domain. This simple difference can be critical to determining the sequence of a fully functional antibody.
Contact UsOur team of antibody & protein engineering experts are well equipped to enhance and de-risk your program’s lead candidate through early development. Abzena have over 20 years of experience in antibody design and protein engineering at our Cambridge facility, and strive to reduce uncertainties in your project, maximizing the likelihood of success. By integrating advanced protein engineering knowledge with cutting-edge analytical techniques, we are able to create optimal drug candidates.
The asset you’re developing right now can make a real difference for human health. Let us use our wealth of experience to deploy the best technologies and solutions, shorten lead times and implement effective risk mitigation strategies.